Loading clinical trials...
Loading clinical trials...
The Effect of Lactobacillus Reuteri ATCC PTA 4659 in Patients With Ulcerative Colitis
Conditions
Interventions
Lactobacillus reuteri
Placebo
Locations
1
Sweden
Uppsala University
Uppsala, Sweden
Start Date
January 1, 2017
Primary Completion Date
January 31, 2019
Completion Date
March 1, 2019
Last Updated
January 14, 2019
Lead Sponsor
Uppsala University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions